Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Statistics

Total Valuation

BNTC has a market cap or net worth of $362.07 million. The enterprise value is $174.27 million.

Market Cap	362.07M
Enterprise Value	174.27M

Important Dates

The last earnings date was Thursday, February 12, 2026, before market open.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

BNTC has 34.25 million shares outstanding. The number of shares has increased by 24.88% in one year.

Current Share Class	34.25M
Shares Outstanding	34.25M
Shares Change (YoY)	+24.88%
Shares Change (QoQ)	+10.72%
Owned by Insiders (%)	2.81%
Owned by Institutions (%)	50.67%
Float	17.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.93
P/TBV Ratio	1.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 67.69, with a Debt / Equity ratio of 0.01.

Current Ratio	67.69
Quick Ratio	67.45
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.50% and return on invested capital (ROIC) is -22.86%.

Return on Equity (ROE)	-33.50%
Return on Assets (ROA)	-22.40%
Return on Invested Capital (ROIC)	-22.86%
Return on Capital Employed (ROCE)	-25.73%
Weighted Average Cost of Capital (WACC)	5.81%
Revenue Per Employee	n/a
Profits Per Employee	-$2.32M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.04% in the last 52 weeks. The beta is 0.29, so BNTC's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-6.04%
50-Day Moving Average	12.22
200-Day Moving Average	13.32
Relative Strength Index (RSI)	36.06
Average Volume (20 Days)	141,492

Short Selling Information

Short Interest	2.09M
Short Previous Month	1.94M
Short % of Shares Out	6.10%
Short % of Float	11.77%
Short Ratio (days to cover)	14.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-48.35M
Pretax Income	-44.11M
Net Income	-44.11M
EBITDA	-48.30M
EBIT	-48.35M
Earnings Per Share (EPS)	-$1.06

Balance Sheet

The company has $188.79 million in cash and $987,000 in debt, with a net cash position of $187.80 million or $5.48 per share.

Cash & Cash Equivalents	188.79M
Total Debt	987,000
Net Cash	187.80M
Net Cash Per Share	$5.48
Equity (Book Value)	187.36M
Book Value Per Share	5.47
Working Capital	186.79M

Cash Flow

In the last 12 months, operating cash flow was -$18.43 million and capital expenditures -$17,000, giving a free cash flow of -$18.44 million.

Operating Cash Flow	-18.43M
Capital Expenditures	-17,000
Free Cash Flow	-18.44M
FCF Per Share	-$0.54

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.88%
Shareholder Yield	-24.88%
Earnings Yield	-12.18%
FCF Yield	-5.09%

Analyst Forecast

The average price target for BNTC is $27.67, which is 161.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$27.67
Price Target Difference	161.78%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 26, 2023. It was a reverse split with a ratio of 1:17.

Last Split Date	Jul 26, 2023
Split Type	Reverse
Split Ratio	1:17

Scores

Altman Z-Score	n/a
Piotroski F-Score	2